市场调查报告书
商品编码
1284302
到 2028 年的可穿戴机器人外骨骼市场预测 - 按类型(被动外骨骼、动力外骨骼)、最终用户(工业、军事和国防、医疗保健、其他最终用户)、地区划分的全球分析Wearable Robotic Exoskeleton Market Forecasts to 2028 - Global Analysis By Type (Passive Exoskeletons and Powered Exoskeletons), End User (Industrial, Military and Defense, Healthcare and Other End Users), and Geography |
根据Stratistics MRC,全球可穿戴机器人外骨骼市场预计2022年将达到7587亿美元,2028年将达到66.41亿美元,复合年增长率为41.4%。
机器人外骨骼是一种可穿戴的机电机器人,由驱动电机、液压和气动系统的计算机控制。 它包括使用执行器、算法、传感器和机械结构执行电机功能的数据收集。 配备机器人外骨骼的专业服务机器人专为提高适应性和安全性而设计。 外骨骼和可穿戴机器人有助于个人移动。 它使瘫痪和中风患者更容易站起来并恢復失去的能力。 外骨骼对工业有很多好处,例如减少与工作相关的事故和疲劳,提高生产力和工作质量。
根据美国心臟协会的数据,超过 650 万美国人患有中风,预计每年还会增加 795,000 人,其中 60% 的人会出现下肢残疾。
机器人外骨骼可用于各种环境,包括消费品和军事应用,以支持人类运动。 人工智能 (Al)、交互式物联网 (loT)、数字助理、虚拟指导和交互式机器人学习等技术发展改善了物流、医疗和工程行业。 机器人技术领域发生了重大变化,特别是引入了针对机器人优化的人在环优化等技术。 因此,这些都是提振该行业的因素。
机动腿部外骨骼已经取得了长足的进步,但它们在不平坦或光滑的表面上行驶仍然存在问题。 此外,该原型机不支持扭转运动,这会使携带负载旋转的用户很快感到疲劳。 这可能会导致不良后果,例如皮肤和组织损伤、骨折等。 为防止市场扩张,监管机构对此类设备製定了特别严格的审批程序。
医疗领域对外骨骼设备的需求正在迅速扩大。 其主要原因是先天性身体虚弱患病率上升、机动车事故增加等因素。 软装轻型可穿戴机器人外骨骼也被证明是一种创新方式,可以帮助儿童和成人康復,以及维持和恢復老年人的步态。 因此,上述原因正在刺激市场的扩张。
可穿戴机器人和外骨骼已被军事和医疗保健行业采用。 外骨骼系统已经用于建筑等商业行业,以提高工人的生产力和熟练程度。 然而,在商业领域实施该解决方案的相关成本对普通人来说是高得吓人的。 可穿戴机器人外骨骼市场的发展受到购买这些设备所需的高初始成本的限制。
对于专注于与医疗保健专业人员和行业合作伙伴合作以解决实际临床挑战并满足患者不断变化的需求的公司而言,这种流行病正在创造巨大的市场前景。 该远程医疗系统旨在为行动不便的患者提供家庭管理和康復治疗。 患者将在临床医生的反馈和监测下接受远程家庭护理。 供应商明白,通过面对面的互动来完成销售流程是增加收入的唯一途径。 由于旅行限制和其他锁定措施,供应商也在努力计划培训课程并及时向客户交货。
据推测,动力外骨骼因其设计而获得了有利可图的增长,这种设计提供背部支撑、感知用户的动作并向管理齿轮的电机发出信号。 动力外骨骼是由电动机、槓桿、液压、气动或这些技术的组合驱动的可穿戴移动设备,可实现更强大、更持久的肢体运动。
医疗保健行业预计在预测期内以最快的复合年增长率增长。 外骨骼产品已广泛应用于医疗保健行业,用于康復训练和帮助部分或完全瘫痪的人。 外骨骼在这个行业拥有广泛的消费群体,加大了新产品的研发投入,为在医疗保健领域占据主导地位铺平了道路。
由于越来越多地采用机器人,预计亚太地区在预测期内将占据最大的市场份额。 韩国和中国因其强大的电子和汽车製造业而成为包括可穿戴机器人在内的机器人技术最重要的市场。 预计该地区在预测期内将快速增长的因素之一是残疾人人数的增加、研发投资的增加以及医疗保健行业的蓬勃发展。
由于自动化物料搬运的普及,预计欧洲在预测期内的复合年增长率最高。 该地区是一些机械化程度最高的行业的所在地。 该地区的最终用户部门也是采用尖端技术的领导者。 地方武装部队也正在开发部队外骨骼机器人。 全球范围内可穿戴机器人市场的增长高度依赖于各种终端用户业务。
2021 年 7 月,Cyber□□dyne Co., Ltd. 将与 J-Workout Co., Ltd. 建立商业联盟,并将于 2021 年 8 月起提供新服务。 我们提供“Neuro HALFIT”服务,该服务通过可穿戴机器人 HAL 激活颅神经系统的激活迴路,从而支持运动功能下降患者的功能改善。
2021 年 3 月,Ekso Bionics 与美国生理协会建立了合作伙伴关係,就 EksoNR 外骨骼的临床疗效对医生进行教育。 该协议将使其他医生和治疗师更加了解 Ekso Bionics 技术以及机器人与康復计划的适当整合。
According to Stratistics MRC, the Global Wearable Robotic Exoskeleton Market is accounted for $758.7 billion in 2022 and is expected to reach $6,064.1 billion by 2028 growing at a CAGR of 41.4% during the forecast period. Robotic exoskeletons are wearable electromechanical robots controlled by computers that drive motor, hydraulic, and pneumatic systems. It comprises gathering data to perform a motor function by using actuators, algorithms, sensors, and mechanical structures. Professional services robots with robotic exoskeletons are designed to increase adaptability and safety. Exoskeletons and wearable robots facilitate personal mobility. They make it easier for paralysed and stroke victims to stand up and regain lost abilities. Exoskeletons have a number of benefits for the industrial sector, such as a decrease in work-related accidents and fatigue as well as improved productivity and work quality.
According to the American Heart Association, more than 6.5 million Americans have had a stroke, with 795,000 additional cases projected each year, and 60 percent of these people expected to have lower-limb disabilities.
Robotic exoskeletons could be employed in a variety of settings, including consumer goods and military use, to support human motions. The development of technology including artificial intelligence (Al), the interactive internet of things (loT), digital assistants, virtual guidance, and interactive robot learning has improved the logistical, medical, and engineering industries. Due to the introduction of techniques, particularly human-in-the-loop optimisation optimised for robots, the robotics sector has seen significant changes. Therefore, these are the factors causing the industry to rise.
Powered lower-limb exoskeletons have come a long way, but users still have trouble navigating uneven or slippery surfaces. Users turning while carrying goods could quickly become exhausted because the prototypes are not yet capable of handling twisting motions. This can lead to undesirable occurrences including skin and tissue damage and bone fractures. In order to prevent the market from expanding, regulatory agencies have set up a particularly stringent clearance process for such devices.
The need for exoskeleton devices in the medical sector is rapidly expanding. This is mostly caused by the rising prevalence of inherited physical infirmities, rise in auto accidents, and other factors. Additionally, the creation of soft-suit, lightweight wearable robotic exoskeleton has demonstrated to be an innovative method to assist children and adults in rehabilitation as well as the elderly in maintaining or regaining their gait. Therefore, the aforementioned reasons are fueling market expansion.
Wearable robots and exoskeletons are employed in the military and healthcare industries. Exoskeleton systems have already begun to be used in commercial industries like construction to boost worker productivity and proficiency. However, the expense associated with implementing the solutions on the commercial sector is prohibitive for regular people. The wearable robotic exoskeleton market's progress is constrained by the expensive initial cost required to buy these devices.
The epidemic has created significant market prospects for companies that focus on resolving genuine clinical challenges in collaboration with healthcare professionals and industry partners and reacting to patients' evolving needs. This telehealth system is intended to enable patients with mobility impairments home-based management and rehabilitation therapies. Patients will receive remote home care with clinician feedback and monitoring. Suppliers understand that the only way to complete the sales process with in-person interaction is to increase revenue. Vendors also struggle to plan training sessions and make timely deliveries to customers owing to travel restrictions and other lockdown measures.
The powered exoskeletons segment is estimated to have a lucrative growth, due to its design offers back support, senses the user's motion, and sends the signal to motors that manage the gears. A powered exoskeleton is a wearable mobile device that is propelled by electric motors, levers, hydraulics, pneumatics, or a combination of these technologies that allows for stronger and more durable limb movement.
The healthcare segment is anticipated to witness the fastest CAGR growth during the forecast period. Exoskeleton products have become widely available in the healthcare industry, and they are used for rehabilitation training and to assist those who are partially or completely paralysed. Exoskeletons in this industry have a wide consumer base, which has led to increased investments in the research and development of new products, paving the way for the healthcare segment to dominate.
Asia Pacific is projected to hold the largest market share during the forecast period owing to the increased adoption of robots across the region. Due of their extensive electronic and automotive manufacturing sectors, South Korea and China are the two most important markets for robotics, including wearable robots. One of the things that is anticipated to ensure that the region grows quicker over the projection period is the rising number of individuals who have disabilities, greater investment on research and development, and the thriving healthcare industry.
Europe is projected to have the highest CAGR over the forecast period, owing to increased use of automated material handling. Some of the most mechanised industries are found in this area. The end-user sectors in the region are also leaders in the adoption of cutting-edge technologies. Exoskeleton robots for troops are also being developed by local militaries. The growth of the wearable robots market on a global scale is significantly influenced by a variety of end-user businesses.
Some of the key players profiled in the Wearable Robotic Exoskeleton Market include Ekso Bionics Holdings Inc., Cyberdyne Inc, Technaid S, Lockheed Martin Corporation, Sarcos Corporation, Honda Motor Co. Ltd, Hocoma AG, ReWalk Robotics Inc., Atoun Inc., Parker Hannifin Corporation, Bionik Laboratories Corporation, Rex Bionics PLC, Bioservo Technologies AB, P & S Mechanics Co.Ltd. and Skelex.
In July 2021, Cyberdyne Inc. has formed a commercial collaboration with J-Workout Inc. to deliver the new service from August 2021. By triggering the activation loop of the brain's nervous system via Wearable Cyborg HAL, the Group delivers Neuro HALFIT as a service to support the functional improvement of patients with decreased motor functions.
In March 2021, Ekso Bionics has established a collaboration with the American Physiatry Society to educate doctors about the clinical benefits of the EksoNR exoskeleton. This agreement will help other physicians & therapists to become more aware of Ekso Bionics technology & a proper integration of robots into rehabilitation programs.